Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
about
Use of Cell-Penetrating Peptides in Dendritic Cell-Based VaccinationIntracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination StrategiesAttachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA.DNA-interactive properties of crotamine, a cell-penetrating polypeptide and a potential drug carrierMechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.Cell penetrating peptides in the delivery of biopharmaceuticals.Versatile RNA interference nanoplatform for systemic delivery of RNAs.An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform.Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing.Delivery of siRNA therapeutics: barriers and carriers.Electroporation and microinjection successfully deliver single-stranded and duplex DNA into live cells as detected by FRET measurements.Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group.Assessment of RNA carrier function in peptide amphiphiles derived from the HIV fusion peptideA role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittinSystemic Administration of siRNA via cRGD-containing Peptide.Preparation and In Vivo Evaluation of Dichloro(1,2-Diaminocyclohexane)platinum(II)-Loaded Core Cross-Linked Polymer MicellespH-Triggered, Macromolecule-Sized Poration of Lipid Bilayers by Synthetically Evolved Peptides.Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo.Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery SystemsCell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.Melittin derived peptides for nanoparticle based siRNA transfection.Sticky nanoparticles: a platform for siRNA delivery by a bis(zinc(II) dipicolylamine)-functionalized, self-assembled nanoconjugate.Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptides.RNAi Therapeutic Platforms for Lung Diseases.Plasma membrane recovery kinetics of a microfluidic intracellular delivery platform.Silk-based delivery systems of bioactive molecules.Current developments in the therapy of protozoan infections.Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery.Action and reaction: the biological response to siRNA and its delivery vehicles.Cell-penetrating peptides for the delivery of nucleic acids.Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma.Cell-penetrating peptides as a novel transdermal drug delivery system.Therapeutic potential of cell-penetrating peptides.Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges.RNAi Therapeutics in Autoimmune Disease.Peptide vectors for gene delivery: from single peptides to multifunctional peptide nanocarriers.
P2860
Q26764861-A061C6CC-9E04-47C1-B148-1778687BA4D5Q26795943-33436C04-E1A8-46DA-AE35-CC3F2D27C976Q27318674-8B9E2FC4-6FF6-426F-B716-0F2138693C25Q28485113-4B24F716-6E4E-4515-B769-851707F3FF26Q33581506-9B5DFD76-96BE-488B-B97E-4E85513ECEA0Q33649501-065EBAAE-79D0-4C78-8D6D-E3B0683BCD1EQ33716038-2F3F48B5-C7B4-42F9-A1AE-E32D5625B41CQ33811185-E36389BE-6063-40C4-8783-807F9354142FQ33875414-DE7A199F-1D31-4E46-9747-46AA9EC88947Q34293708-7FC732A9-8850-4382-AD34-EFBE659C50A1Q35154985-EA34FDAC-198F-4587-9BB7-27AFCDE51445Q35823611-69B20421-8564-417B-8899-8D6C7F61E77BQ35961900-2A774C3A-FEDC-4C87-8896-B62E701F0C1CQ35967737-122A2A89-88BA-4E21-8BFE-735385449A51Q35989535-82D301C5-8D4A-41E4-88B6-496B1FD7C22DQ36111392-B11C3FD4-5B62-4E96-ABAA-AAE1B9437448Q36230180-F47FF06A-DEBF-4BC8-A1B0-A1E2E1A0A995Q36283436-A893F7E1-E0F7-47E5-BC18-04E295CC7ECFQ36341433-71E9A00C-2C41-464B-ABC7-D60FD7224B5BQ36414890-E3F54233-E838-4469-98FC-2AB71485D9DAQ36512557-CB4FEFB8-1EC4-4F1B-B002-1D5E17807CE6Q36626455-36D00189-FB60-47B3-80E2-9E0E70A3F911Q36755506-D0563F9A-55B0-4EE3-9DC1-E76D1306DA57Q36763633-36ECF8AA-BFE6-4970-88E6-A7CFDFEA3D10Q36996266-A3374E41-F604-4FCF-B0A9-00AB0B8D23D4Q37277373-AB789038-69FF-449F-BB66-2BD7C498DA17Q37666064-3CAD7129-9C68-4BE9-891E-D35303A05A5FQ37714025-DC5E3345-E745-420B-B5C0-EF08DB5D407DQ37883063-B3BD7C73-569B-47A8-8E66-7A010C1D8F64Q37944929-ACB0E823-3000-4A60-8845-BBEE51BE2971Q37950261-D4687050-0460-4587-9FDF-67E39168D880Q37974719-F65C8379-BC81-4B5D-A43B-4B93A2AD9855Q37976576-D89E27E7-CCB6-45EE-8BCD-426C71AD5245Q38010767-7E03968C-19CB-495F-93DD-4799C5F2B602Q38030642-C7C6C103-DA1F-4DBA-A09B-0BB883498D2EQ38030731-D9EB77E4-0EB6-4DFB-8AB9-F7039F487BB7Q38104407-34C31020-3D9D-4559-AD1B-633815508702Q38106032-0A21FDA9-DDB0-468E-8AB4-3C78CC7B84F9Q38166206-12A4FB25-8326-4EC4-9CE3-672D67A54C1BQ38269128-8FD62F9E-4955-4DC4-A38C-80CEA4247371
P2860
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
@en
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
@nl
type
label
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
@en
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
@nl
prefLabel
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
@en
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
@nl
P1476
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
@en
P2093
Takashi Ohtsuki
Tamaki Endoh
P304
P356
10.1016/J.ADDR.2009.04.005
P407
P577
2009-04-19T00:00:00Z